| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Revenue | $705K | -61.0% |
| R&D Expense | $52.0M | -39.1% |
| SG&A Expense | $26.7M | +13.3% |
| Operating Income | -$72.1M | +16.4% |
| Interest Expense | $4.4M | +1466.2% |
| Pre-tax Income | -$78.8M | +11.1% |
| Net Income | -$78.8M | +11.1% |
| EPS (Basic) | -$0.41 | +57.3% |
| EPS (Diluted) | -$0.41 |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $348.6M | +385.6% |
| Accounts Receivable | $349K | -76.2% |
| Current Assets | $656.7M | +574.9% |
| Total Assets | $664.2M | +485.8% |
| Current Liabilities | $38.8M | +51.4% |
| Total Liabilities | $537.5M | +1686.4% |
| Stockholders' Equity | $126.7M | +52.1% |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$41.6M | +42.7% |
| Capital Expenditures | $624K | +103.9% |
| Investing Cash Flow | -$624K | -103.9% |
| Financing Cash Flow | $620.2M | +696.0% |
| Free Cash Flow | -$42.2M | +42.1% |
| +57.3% |